Caregivers
This presentation (18:41 minutes) given by Natalie Manley, MD, MPH on November 7th, 2019 and discusses caregivers, difficulties involved with caregiving, and resources for caregivers.
Cognitive Testing
This presentation (34:53 minutes) given by Thuy Koll, MD and discusses cognitive testing options for the geriatric population. Topics include: An overview of cognitive testing, how the cognition changes as a patient ages, how to pick which tests to use, and a variety of different cognitive tests (including the Clock-Draw-Test, Mini-Cog, MoCA, CERAD, and RBANS)
Interprofessional Oral Health Resources for Healthy Aging Month!
September is Healthy Aging Month, giving health professionals the opportunity to recognize the importance of oral health in promoting overall positive health outcomes as we age. Year-round, OHNEP enhances the nursing profession’s interprofessional role in oral health and its links to overall health in both academic and clinical settings. Adopting healthy habits and lifestyle changes - regular exercise, a nutritious diet, improved sleep patterns - are ways we can overcome health physical and mental health challenges that occur with age.
#NexusSummit2023 plenary features a panel of physician leaders as they discuss their unique opportunities and responsibilities to transform US healthcare to leverage effective interprofessional teamwork to achieve outcomes that matter most. Register today
#NexusSummit2023 plenary features a panel of physician leaders as they discuss their unique opportunities and responsibilities to transform US healthcare to leverage effective interprofessional teamwork to achieve outcomes that matter most. Don't miss the conversation. Register today!
Lecanemab Frequently Asked Questions
On July 6, 2023, the Food and Drug Administration (FDA) provided approval for lecanemab (Leqembi) to treat early-stage Alzheimer’s disease. Lecanemab is a medication developed by Eisai and Biogen that may help slow the progression of early stage Alzheimer’s disease. Many people living with dementia, families, and care professionals have questions regarding this news. This document contains frequently asked questions and some answers for a better understanding of what to expect with the FDA approval of lecanemab.